UK-US Drugs Deal: When Bad Research Makes Good Headlines
The pharmaceutical agreement between the UK and the United States was signed last year, but it has suddenly become politically controversial. Incoming Prime Minister Andy Burnham is under pressure to cancel or renegotiate it. The broad bargain was straightforward. The deal has returned to the headlines because of a paper published in the British Medical … Read more
